News Center

News Center

Home page

Blog Center

News Center

Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA

Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA

Viwit's Nitroglycerin Sublingual Tablets Approved by FDA

Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated"

Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US.

Viwit Pharmaceutical’s Lifitegrast API has completed registrations in both China and the US!

In 2022

Viwit Pharmaceutical Co., Ltd. participated in CPHI Worldwide 2022 held in Frankfurt Germany from November 1st to November 3rd.

Viwit Pharmaceutical Co., Ltd. participated in CPHI Worldwide 2022 held in Frankfurt Germany from November 1st to November 3rd.

As the world's largest pharmaceutical industry exhibition, CPHI has been successfully held for 30 years. It displays the entire pharmaceutical supply chain, from API, P-MEC to FDF. It becomes the largest annual gathering of pharmaceutical professionals all over the world. Viwit met old friends and new business partners at CPHI. We displayed a wonderful enterprise image with our products and services, and promoted our international business through CPHI.

09

2022

/

11

< 1 >

VIWIT

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search